Blog
Does the US need to invest more in biomedical research?
According to a recent article by Senator Amy Klobuchar, the United States has always been the world leader when it comes to biomedical research and innovation. However, many other countries are starting to rapidly catch up, and the United States may need to put more...
FDA: Using EHR-EDC for clinical trials?
The US Food and Drug Administration (FDA) has been looking into ways to test Electric Health Record (EHR)-to-Electric Data Capture (EDC) approach for clinical trials. The administration believes that this could open up new opportunities for clinical trials through...
Pearl Pathways hires Patti Hunker
Pearl Pathways is excited to add Patti Hunker to their team as the senior leader in clinical research and management of foundation as Clinical Research Advisor. Hunker has over 10 years of clinical research experience in both drug and device trials. Previously, she...
A cancer patient’s perspective on drivers of low participation rates in clinical trials
Stan Collender, a cancer patient, shares an interesting New York Times op ed piece on why so few cancer patients participate in clinical trials. Stan is a diagnosed with Merkel cell carcinoma (a rare skin cancer) and is enrolled in a clinical trial with, in his...
Pearl Pathway is expanding!
Pearl Pathways has expanded and is thrilled to announce its hiring of John Lockwood as their new Regulatory Compliance Advisor. Lockwood has over 20 years of experience in quality, regulatory, auditing, and purchasing roles in the life sciences industry. In addition...